News, events, updates, breakthroughs. Press announcements are archived by release date, searchable by topic: Latest Press Releases - May 17, 2012
Positive Phase 2 Clinical Data With Tivantinib in Hepatocellular Carcinoma to be Highlighted in Oral - March 27, 2012
Centennial Tree Planting Ceremony Commemorates - March 08, 2012
Chef Becker Announces Franklin’s Family Fixin’s Contest Winner - December 15, 2011
Future Demand For Science Talent Grows In Garden State - December 12, 2011
Pooled results of the STARS E-III and STARS J-V studies presented at ASH 2011 - November 16, 2011
New Analysis of Data Presented at AHA Regarding Effect of Effient (Prasugrel) on Cardiovascular - November 10, 2011
Daiichi Sankyo to License ARQ 92 from ArQule - October 21, 2011
Daiichi Sankyo, Inc. Brings the Legacy of Washington, DC Cherry Trees to New Jersey - September 08, 2011
Renowned Chef Launches "Franklin's Family Fixin's" Offering Adults with Type 2 D - August 17, 2011
Daiichi Sankyo, Inc. Appoints Executive Vice President of Drug Development For The Americas - August 17, 2011
FDA Approval of ZelborafTM (vemurafenib) Establishes Oncology Foothold in US for Daiichi Sankyo - August 11, 2011
Effient® Showed Significant 26 Percent Reduction in Cardiovascular Events Over Plavix® in New Core C - July 25, 2011
Welchol OS FDA Beverage Approval - July 19, 2011
Daiichi Sankyo Launches LIXIANA® (edoxaban), a Direct Oral Factor Xa Inhibitor, in Japan for the Pre - June 28, 2011
Daiichi Sankyo, Inc. Names Danesha Dixon Smith Vice President of Human Resources - May 23, 2011
Study Finds Long-Term Treatment with TRIBENZOR was Effective and Well-Tolerated Regardless of Age, - May 20, 2011
Local Partnership Addresses Lagging Scores and Interest in Science and Math Among Students - May 17, 2011
Regency Therapeutics and Daiichi Sankyo Announce Launch and Commercial Availability of SPRIX® (ketor - May 11, 2011
Vemurafenib New Drug Application Submitted to FDA for Melanoma | |
